| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ITCH_0000200 | Exon-Exon | chr20:32951062-32981687 | chr20:34363256-34393881 | 262 nt | 0.5382 |
| hsa_ITCH_0000300 | Exon-Exon | chr20:32951062-33037285 | chr20:34363256-34449480 | 1402 nt | 0.4572 |
| hsa_ITCH_0001000 | Exon-Exon | chr20:32957200-32981687 | chr20:34369394-34393881 | 168 nt | 0.4702 |
| hsa_ITCH_0001100 | Exon-Exon | chr20:32957200-32996598 | chr20:34369394-34408792 | 310 nt | 0.4419 |
| hsa_ITCH_0001200 | Exon-Exon | chr20:32957200-33001685 | chr20:34369394-34413879 | 573 nt | 0.4136 |
| hsa_ITCH_0001300 | Exon-Exon | chr20:32957200-33028149 | chr20:34369394-34440344 | 1090 nt | 0.4495 |
| hsa_ITCH_0002100 | Exon-Exon | chr20:32957200-33059320 | chr20:34369394-34471515 | 1667 nt | 0.4397 |
| hsa_ITCH_0002200 | Exon-Exon | chr20:32957200-33068537 | chr20:34369394-34480732 | 2050 nt | 0.4302 |
| hsa_ITCH_0004800 | Exon-Exon | chr20:32981597-33001685 | chr20:34393791-34413879 | 496 nt | 0.4012 |
| hsa_ITCH_0005500 | Exon-Exon | chr20:32981597-33012331 | chr20:34393791-34424525 | 542 nt | 0.4059 |
A review consolidating research in humans and model organisms indicates that the circITCH functions as a tumor suppressor in glioma by sponging miR-214 to allow expression of ubiquitin-protein ligase E3, thereby suppressing proliferation and preventing apoptosis, while also targeting the Wnt/β-catenin pathway [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746]. In oesophageal squamous cell carcinoma, the circITCH is downregulated and increases ITCH expression to inhibit the Wnt/β-catenin pathway [Lee et al. DOI:10.1016/j.biopha.2018.12.052]. circITCH hsa_circ_0001141 (circITCH) was found to be lower in the hearts of cancer patients suffering from doxorubicin-induced cardiomyopathy compared to those with dilated cardiomyopathy, hypertrophic cardiomyopathy, and healthy donors, and its expression ameliorates doxorubicin-induced cardiomyocyte injury [Tian et al. DOI:10.3390/molecules26041155].